Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Katharina Axtmann Petersen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.5% 1.9% 2.1% 2.0% 1.6% 1.7% 6.4% 6.4%   Credit score (0-100)   55 70 66 68 73 73 37 37   Credit rating   BBB A A A A A BBB BBB   Credit limit (kDKK)   0.0 0.5 0.1 0.4 7.1 4.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,712 2,790 3,054 3,394 3,719 4,599 0.0 0.0   EBITDA   826 1,126 1,272 1,504 1,888 1,971 0.0 0.0   EBIT   619 919 1,066 1,296 1,669 1,598 0.0 0.0   Pre-tax profit (PTP)   143.6 479.1 650.1 934.9 1,655.9 1,504.9 0.0 0.0   Net earnings   44.4 313.5 447.9 715.1 1,295.9 1,086.9 0.0 0.0   Pre-tax profit without non-rec. items   144 479 650 935 1,656 1,505 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   3,416 3,299 3,182 3,108 4,214 3,968 0.0 0.0   Shareholders equity total   560 763 1,098 1,699 2,877 3,842 3,668 3,668   Interest-bearing liabilities   2,625 1,875 670 183 2,046 749 0.0 0.0   Balance sheet total (assets)   5,170 5,006 4,803 5,177 6,744 5,320 3,668 3,668   Net Debt   2,618 1,875 670 183 1,704 749 -2,571 -2,571     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,712 2,790 3,054 3,394 3,719 4,599 0.0 0.0   Gross profit growth   -9.3% 2.9% 9.5% 11.1% 9.6% 23.7% -100.0% 0.0%   Employees   3 3 7 4 4 4 0 0   Employee growth %   -25.0% 0.0% 133.3% -42.9% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,170 5,006 4,803 5,177 6,744 5,320 3,668 3,668   Balance sheet change%   0.3% -3.2% -4.1% 7.8% 30.3% -21.1% -31.1% 0.0%   Added value   825.7 1,125.7 1,272.2 1,503.8 1,877.2 1,971.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   807 -413 -413 -372 798 -708 -3,968 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.8% 32.9% 34.9% 38.2% 44.9% 34.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.4% 14.0% 17.5% 20.4% 29.3% 26.7% 0.0% 0.0%   ROI %   10.0% 20.7% 29.0% 36.0% 38.5% 29.2% 0.0% 0.0%   ROE %   7.5% 47.4% 48.1% 51.1% 56.6% 32.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   10.8% 15.3% 23.0% 32.9% 42.7% 72.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   317.1% 166.5% 52.7% 12.2% 90.3% 38.0% 0.0% 0.0%   Gearing %   468.8% 245.7% 61.0% 10.8% 71.1% 19.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.1% 10.3% 16.5% 19.9% 8.4% 7.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.1 0.1 0.3 0.5 0.1 0.0 0.0   Current Ratio   0.1 0.1 0.1 0.3 0.5 0.2 0.0 0.0   Cash and cash equivalent   7.4 0.0 0.0 0.0 342.3 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,498.1 -2,756.3 -2,562.5 -1,586.7 -1,364.9 -893.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   275 375 182 376 469 493 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   275 375 182 376 472 493 0 0   EBIT / employee   206 306 152 324 417 399 0 0   Net earnings / employee   15 105 64 179 324 272 0 0